Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled studyThe Lancet (British edition), 2009-11, Vol.374 (9701), p.1606-1616 [Peer Reviewed Journal]Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Nov 7-Nov 13, 2009 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61375-1 ;PMID: 19853906 ;CODEN: LANCAOFull text available |
|
2 |
Material Type: Article
|
Tolerability of nausea and vomiting and associations with weight loss in a randomized trial of liraglutide in obese, non-diabetic adultsInternational Journal of Obesity, 2014-05, Vol.38 (5), p.689-697 [Peer Reviewed Journal]2015 INIST-CNRS ;COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group May 2014 ;Copyright © 2014 Macmillan Publishers Limited 2014 Macmillan Publishers Limited ;ISSN: 0307-0565 ;ISSN: 1476-5497 ;EISSN: 1476-5497 ;DOI: 10.1038/ijo.2013.149 ;PMID: 23942319 ;CODEN: IJOBDPFull text available |
|
3 |
Material Type: Article
|
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese SubjectsThe New England journal of medicine, 2010-09, Vol.363 (10), p.905-917 [Peer Reviewed Journal]Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1003114 ;PMID: 20818901 ;CODEN: NEJMAGFull text available |
|
4 |
Material Type: Article
|
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled studyThe Lancet (British edition), 2006-11, Vol.368 (9548), p.1660-1672 [Peer Reviewed Journal]2006 Elsevier Ltd ;Copyright Lancet Ltd. Nov 11-Nov 17, 2006 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(06)69571-8 ;PMID: 17098084 ;CODEN: LANCAOFull text available |
|
5 |
Material Type: Article
|
Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trialEuropean heart journal, 2007-12, Vol.28 (23), p.2915-2923 [Peer Reviewed Journal]The European Society of Cardiology 2007. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org 2007 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehm217 ;PMID: 17595194Full text available |
|
6 |
Material Type: Article
|
ABC of obesity: Management: Part II—DrugsBMJ (Online), 2006-10, Vol.333 (7572), p.794-797 [Peer Reviewed Journal]2006 BMJ Publishing Group Ltd ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.333.7572.794 ;PMID: 17038738Full text available |
|
7 |
Material Type: Article
|
Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and MaintenanceObesity (Silver Spring, Md.), 2011-07, Vol.19 (7), p.1404-1414 [Peer Reviewed Journal]2011 North American Association for the Study of Obesity (NAASO) ;Copyright Nature Publishing Group Jul 2011 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1038/oby.2010.352 ;PMID: 21293451Full text available |
|
8 |
Material Type: Article
|
Early Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in PeriodObesity (Silver Spring, Md.), 2010-05, Vol.18 (5), p.987-994 [Peer Reviewed Journal]2010 North American Association for the Study of Obesity (NAASO) ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1038/oby.2009.327 ;PMID: 19816415Full text available |
|
9 |
Material Type: Article
|
Prediction of response to sibutramine therapy in obese non-diabetic and diabetic patientsDiabetes, obesity & metabolism, 2006-03, Vol.8 (2), p.206-213ISSN: 1462-8902 ;EISSN: 1463-1326 ;DOI: 10.1111/j.1463-1326.2005.00481.x ;PMID: 16448525Full text available |
|
10 |
Material Type: Article
|
Leisure-time activity is an important determinant of long-term weight maintenance after weight loss in the Sibutramine Trial on Obesity Reduction and Maintenance (STORM trial)The American journal of clinical nutrition, 2003-08, Vol.78 (2), p.209-214 [Peer Reviewed Journal]2004 INIST-CNRS ;Copyright American Society for Clinical Nutrition, Inc. Aug 2003 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.1093/ajcn/78.2.209 ;PMID: 12885699 ;CODEN: AJCNACFull text available |
|
11 |
Material Type: Article
|
Emerging pharmacotherapy for treating obesity and associated cardiometabolic riskAsia Pacific journal of clinical nutrition, 2006-09, Vol.15 Suppl, p.55 [Peer Reviewed Journal]ISSN: 0964-7058 ;EISSN: 1440-6047 ;PMID: 16928662Full text available |
|
12 |
Material Type: Article
|
Current approaches to obesity management in UK primary care: the counterweight programmeJournal of human nutrition and dietetics, 2004-06, Vol.17 (3), p.183-190 [Peer Reviewed Journal]2004 INIST-CNRS ;Copyright Blackwell Scientific Publications Ltd. Jun 2004 ;ISSN: 0952-3871 ;EISSN: 1365-277X ;DOI: 10.1111/j.1365-277X.2004.00528.x ;PMID: 15139890Full text available |
|
13 |
Material Type: Article
|
Present and future pharmacological approachesBritish medical bulletin, 1997, Vol.53 (2), p.409-432 [Peer Reviewed Journal]ISSN: 0007-1420 ;EISSN: 1471-8391 ;DOI: 10.1093/oxfordjournals.bmb.a011620 ;PMID: 9246843Full text available |
|
14 |
Material Type: Article
|
Drug therapy for management of obesityThe Lancet (British edition), 2001-04, Vol.357 (9264), p.1287-1287 [Peer Reviewed Journal]2001 Elsevier Ltd ;Copyright National Library of Medicine - MEDLINE Abstracts Apr 21 2001 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(00)04424-X ;PMID: 11421206 ;CODEN: LANCAOFull text available |